Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Does place of service matter? A utilisation and cost analysis of sexually transmissible infection testing from 2012 claims data

Does place of service matter? A utilisation and cost analysis of sexually transmissible infection... BackgroundIn this study, a previous study on the utilisation and cost of sexually transmissible infection (STI) tests was augmented by focusing on outpatient place of service for the most utilised tests. Methods: Claims for eight STI tests [chlamydia, gonorrhoea, hepatitis B virus (HBV), HIV, human papillomavirus (HPV), herpes simplex virus type 2 (HSV2), syphilis and trichomoniasis] using the most utilised current procedural terminology (CPT) code for each STI from the 2012 MarketScan outpatient table were extracted. The volume and costs by gender and place of service were then summarised. Finally, semi-log regression analyses were used to further examine and compare costs. Results: Females had a higher number of test claims than males in all places of service for each STI. Together, claims from Independent Laboratories, Office and Outpatient hospital accounted for over 93% of all the test claims. The cost of tests were slightly (<5%) different between males and females for most places of service. Except for the estimated average cost for Outpatient hospital, the estimated average costs for the other categories were significantly lower (1580%, P<0.01) than the estimated average cost for Emergency Room Hospital for all the STIs. Among the predominant service venues, test costs from Independent Laboratory and Office were 30% to 69% lower (P<0.01) than those from Outpatient Hospital. Conclusions: Even though the results from this study are not generalisable, our study shows that almost all STI tests from outpatient claims data were performed in three service venues with considerable cost variations. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Sexual Health CSIRO Publishing

Does place of service matter? A utilisation and cost analysis of sexually transmissible infection testing from 2012 claims data

Owusu-Edusei, Kwame; Patel, Chirag G.; Gift, Thomas L.
Sexual Health , Volume 13 (2): 9 – Jan 18, 2016
Download PDF
9 pages

Loading next page...
 
/lp/csiro-publishing/does-place-of-service-matter-a-utilisation-and-cost-analysis-of-qY2ULKJ0Qb

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
CSIRO Publishing
Copyright
Copyright © The Author(s). Published by CSIRO Publishing
ISSN
1448-5028
eISSN
1449-8987
DOI
10.1071/SH15066
pmid
26774890
Publisher site
See Article on Publisher Site

Abstract

BackgroundIn this study, a previous study on the utilisation and cost of sexually transmissible infection (STI) tests was augmented by focusing on outpatient place of service for the most utilised tests. Methods: Claims for eight STI tests [chlamydia, gonorrhoea, hepatitis B virus (HBV), HIV, human papillomavirus (HPV), herpes simplex virus type 2 (HSV2), syphilis and trichomoniasis] using the most utilised current procedural terminology (CPT) code for each STI from the 2012 MarketScan outpatient table were extracted. The volume and costs by gender and place of service were then summarised. Finally, semi-log regression analyses were used to further examine and compare costs. Results: Females had a higher number of test claims than males in all places of service for each STI. Together, claims from Independent Laboratories, Office and Outpatient hospital accounted for over 93% of all the test claims. The cost of tests were slightly (<5%) different between males and females for most places of service. Except for the estimated average cost for Outpatient hospital, the estimated average costs for the other categories were significantly lower (1580%, P<0.01) than the estimated average cost for Emergency Room Hospital for all the STIs. Among the predominant service venues, test costs from Independent Laboratory and Office were 30% to 69% lower (P<0.01) than those from Outpatient Hospital. Conclusions: Even though the results from this study are not generalisable, our study shows that almost all STI tests from outpatient claims data were performed in three service venues with considerable cost variations.

Journal

Sexual Health – CSIRO Publishing

Published: Jan 18, 2016

References

  • Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.
    Satterwhite CL Torrone E Meitis E Dunne EF Mahajan R Ocfemia MCB Su J Xu F Weinstock H
  • The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008.
    Owusu-Edusei K Jr Chesson HW Gift TL Tao G Mahajan R Ocfemia MC Kent CK
  • Sexually transmitted diseases treatment guidelines, 2010.
    Workowski KA Berman S
  • Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae –2014.
    Centers for Disease Control; Prevention
  • Utilization and cost of diagnostic methods for sexually transmitted infection screening among insured American youth, 2008.
    Owusu-Edusei K Jr Nguyen HT Gift TL
  • Hospitalization cost per case of neonatal herpes simplex virus infection from claims data.
    Owusu-Edusei K Jr Flagg EW Gift TL
  • Hospitalization cost of congenital syphilis diagnosis from insurance claims data in the United States.
    Owusu-Edusei K Jr Introcaso CE Chesson HW
  • Use and costs of care in retail clinics versus traditional care sites.
    Thygeson M Van Vorst KA Maciosek MV Solberg L
  • The costs of visits to emergency departments.
    Williams RM
  • Comparing costs and quality of care at retail clinics with that of other medical settings for 3 common illnesses.
    Mehrotra A Liu H Adams JL Wang MC Lave JR Thygeson NM Solberg LF McGlynn EA
  • Chlamydia screening and pelvic inflammatory disease: insights from exploratory time-series analyses.
    Owusu-Edusei K Jr Bohm MK Chesson HW Kent CK
  • The growing power of some providers to win steep payment increases from insurers suggests policy remedies may be needed.
    Berenson RA Ginsburg PB Christianson JB Yee T
  • Quality of diagnosis and procedure coding in ICD-10 administrative data.
    Henderson T Shepheard J Sundararajan V
  • Assessing the accuracy of administrative data in health information systems.
    Peabody JW Luck J Jain S Bertenthal D Glassman P
  • Improving clinical operations: can we and should we save our STD clinics?
    Golden MR Kerndt PR
  • County-level sexually transmitted disease detection and control in Texas: do sexually transmitted diseases and family planning clinics matter?
    Owusu-Edusei K Jr Doshi SR